CD38 and Miyoshi myopathy: Interaction of all‐trans retinoic acid (ATRA) with nuclear retinoic acid receptors results in induction of CD38 expression 69, 108, 109, which significantly improved daratumumab‐mediated ADCC and CDC against MM cells 69.